Kabukcuoglu S, Ozalp S S, Oner U, Bildirici K, Yalcin O T, Oge T, Colak E
Department of Pathology, University of Eskisehir Osmangazi School of Medicine, Eskisehir, Turkey.
Eur J Gynaecol Oncol. 2006;27(2):123-8.
The aim of the study was to compare the fascin expression pattern and histopathologic features of malign epithelial ovarian tumors obtained by the primary and secondary surgeries.
The samples of 94 epithelial ovarian carcinomas, 35 secondary surgeries for ovarian carcinomas, 13 borderline epithelial ovarian tumors, 25 cystadenomas and four normal ovarian tissues were stained by means of fascin immunohistochemistry. Secondary surgeries included in the study were secondary cytoreduction at the time of second-look laparotomy (SLL), interval debulking surgery after neoadjuvant chemotherapy or secondary cytoreductive surgery in patients with recurrent epithelial ovarian carcinoma.
Mean rank value of the stromal fascin score was higher in 94 cases of malign epithelial ovarian carcinomas than borderline epithelial tumors, cystadenomas and normal ovaries (.000, p < 0.001). There was no significant difference in terms of total epithelial fascin score (.685, p > 0.05) and total stromal fascin score (.572, p > 0.05) between the primary and the secondary surgeries of epithelial ovarian carcinomas.
Regarding the results of stromal fascin expression in 94 epithelial ovarian carcinomas, we hypothesized that cell-matrix interaction was an important step in the progression of malign epithelial ovarian neoplasms. Our study showed that the initial tumorigenic phenotype did not change with time and use of cisplatinum-based combination chemotherapy. Further studies with close follow-up of patients are necessary to reveal the role of fascin on matrix degradation mechanisms which might be the cause of the recurrences in ovarian neoplasms.
本研究旨在比较初次手术和二次手术获取的恶性上皮性卵巢肿瘤的成束蛋白表达模式和组织病理学特征。
采用成束蛋白免疫组织化学方法对94例上皮性卵巢癌样本、35例卵巢癌二次手术样本、13例交界性上皮性卵巢肿瘤样本、25例囊腺瘤样本和4例正常卵巢组织样本进行染色。本研究纳入的二次手术包括二次探查剖腹术(SLL)时的二次肿瘤细胞减灭术、新辅助化疗后的间隔性肿瘤细胞减灭术或复发性上皮性卵巢癌患者的二次肿瘤细胞减灭术。
94例恶性上皮性卵巢癌的基质成束蛋白评分平均秩次高于交界性上皮性肿瘤、囊腺瘤和正常卵巢(.000,p < 0.001)。上皮性卵巢癌初次手术和二次手术之间,上皮成束蛋白总分(.685,p > 0.05)和基质成束蛋白总分(.572,p > 0.05)无显著差异。
基于94例上皮性卵巢癌基质成束蛋白表达结果,我们推测细胞 - 基质相互作用是恶性上皮性卵巢肿瘤进展的重要步骤。我们的研究表明,初始致瘤表型不会随时间和基于顺铂的联合化疗的使用而改变。有必要对患者进行密切随访的进一步研究,以揭示成束蛋白在基质降解机制中的作用,而基质降解机制可能是卵巢肿瘤复发的原因。